Moldova vs Qatar: Access to anti-retroviral drugs, male (%)
Moldova
47.0%
in 2024
Qatar
47.0%
in 2024
Moldova rank
122nd
Qatar rank
122nd
Access to anti-retroviral drugs, male (%) over time
- Moldova
- Qatar
How they compare
Moldova currently reports 47.0% against 47.0% in Qatar, a difference of 0.0%.
The two have swapped places 2 times across 17 shared years of data; in 2000 it was Qatar ahead.
Moldova ranks 122nd and Qatar ranks 122nd of 141 countries.
Across the 3 decades both report, Moldova averaged higher in 1 and Qatar in 2.
Head to head by decade
| Decade | Moldova | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.3% | 0.0% | 0.3% | Moldova |
| 2010s | 23.0% | 38.4% | 15.4% | Qatar |
| 2020s | 39.2% | 45.2% | 6.0% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Moldova or Qatar?
- Moldova, at 47.0% against 47.0% in Qatar as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Moldova and Qatar?
- 0.0%, with Moldova ahead.
- How many years of comparable data are there for Moldova and Qatar?
- 17 years are reported by both, from 2000 to 2024.
- How do Moldova and Qatar rank globally for access to anti-retroviral drugs, male?
- Moldova ranks 122nd and Qatar ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.